216 related articles for article (PubMed ID: 31451652)
1. Single-cell imaging reveals unexpected heterogeneity of telomerase reverse transcriptase expression across human cancer cell lines.
Rowland TJ; Dumbović G; Hass EP; Rinn JL; Cech TR
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18488-18497. PubMed ID: 31451652
[TBL] [Abstract][Full Text] [Related]
2. Allele-specific proximal promoter hypomethylation of the telomerase reverse transcriptase gene (TERT) associates with TERT expression in multiple cancers.
Rowland TJ; Bonham AJ; Cech TR
Mol Oncol; 2020 Oct; 14(10):2358-2374. PubMed ID: 33245585
[TBL] [Abstract][Full Text] [Related]
3. Nuclear compartmentalization of TERT mRNA and TUG1 lncRNA is driven by intron retention.
Dumbović G; Braunschweig U; Langner HK; Smallegan M; Biayna J; Hass EP; Jastrzebska K; Blencowe B; Cech TR; Caruthers MH; Rinn JL
Nat Commun; 2021 Jun; 12(1):3308. PubMed ID: 34083519
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
Yuan X; Larsson C; Xu D
Oncogene; 2019 Aug; 38(34):6172-6183. PubMed ID: 31285550
[TBL] [Abstract][Full Text] [Related]
5. Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.
Wu RC; Ayhan A; Maeda D; Kim KR; Clarke BA; Shaw P; Chui MH; Rosen B; Shih IeM; Wang TL
J Pathol; 2014 Mar; 232(4):473-81. PubMed ID: 24338723
[TBL] [Abstract][Full Text] [Related]
6. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.
Avin BA; Wang Y; Gilpatrick T; Workman RE; Lee I; Timp W; Umbricht CB; Zeiger MA
Genes Chromosomes Cancer; 2019 Aug; 58(8):530-540. PubMed ID: 30664813
[TBL] [Abstract][Full Text] [Related]
8. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.
McKelvey BA; Gilpatrick T; Wang Y; Timp W; Umbricht CB; Zeiger MA
Thyroid; 2020 Oct; 30(10):1470-1481. PubMed ID: 32228178
[No Abstract] [Full Text] [Related]
10. Molecular cloning of the canine telomerase reverse transcriptase gene and its expression in neoplastic and non-neoplastic cells.
Yazawa M; Okuda M; Kanaya N; Hong SH; Takahashi T; Ohashi E; Nakagawa T; Nishimura R; Sasaki N; Masuda K; Ohno K; Tsujimoto H
Am J Vet Res; 2003 Nov; 64(11):1395-400. PubMed ID: 14620776
[TBL] [Abstract][Full Text] [Related]
11. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation of the TERT promoter and its impact on human cancer.
Lee DD; Komosa M; Nunes NM; Tabori U
Curr Opin Genet Dev; 2020 Feb; 60():17-24. PubMed ID: 32114294
[TBL] [Abstract][Full Text] [Related]
13. Exploring the epigenetic regulation of telomerase reverse transcriptase (TERT) in human cancer cell lines.
McKelvey BA; Zeiger MA; Umbricht CB
Mol Oncol; 2020 Oct; 14(10):2355-2357. PubMed ID: 32920953
[TBL] [Abstract][Full Text] [Related]
14. Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
Borah S; Xi L; Zaug AJ; Powell NM; Dancik GM; Cohen SB; Costello JC; Theodorescu D; Cech TR
Science; 2015 Feb; 347(6225):1006-10. PubMed ID: 25722414
[TBL] [Abstract][Full Text] [Related]
15. Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization.
Muzza M; Colombo C; Rossi S; Tosi D; Cirello V; Perrino M; De Leo S; Magnani E; Pignatti E; Vigo B; Simoni M; Bulfamante G; Vicentini L; Fugazzola L
Mol Cell Endocrinol; 2015 Jan; 399():288-95. PubMed ID: 25448848
[TBL] [Abstract][Full Text] [Related]
16. TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
Svahn F; Paulsson JO; Stenman A; Fotouhi O; Mu N; Murtha TD; Korah R; Carling T; Bäckdahl M; Wang N; Juhlin CC; Larsson C
Int J Mol Med; 2018 Sep; 42(3):1675-1683. PubMed ID: 29956721
[TBL] [Abstract][Full Text] [Related]
17. Identification of PITX1 as a TERT suppressor gene located on human chromosome 5.
Qi DL; Ohhira T; Fujisaki C; Inoue T; Ohta T; Osaki M; Ohshiro E; Seko T; Aoki S; Oshimura M; Kugoh H
Mol Cell Biol; 2011 Apr; 31(8):1624-36. PubMed ID: 21300782
[TBL] [Abstract][Full Text] [Related]
18. Telomerase Biology Associations Offer Keys to Cancer and Aging Therapeutics.
Smith-Sonneborn J
Curr Aging Sci; 2020; 13(1):11-21. PubMed ID: 31544708
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific expression of telomerase reverse transcriptase gene variants in Nicotiana tabacum.
Jurečková JF; Sýkorová E; Hafidh S; Honys D; Fajkus J; Fojtová M
Planta; 2017 Mar; 245(3):549-561. PubMed ID: 27900472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
